the Soy Story
HOME MEDIA RELEASES WHAT'S NEW IN RESEARCH? INTERVIEW CONTACTS GLOSSARY
Search
Introduction from Sanitarium
International Soy Advisory Board
What is Soy?
Soy Foods for Health
Soy and Heart Disease
Soy and Cancer
Soy and Osteoporosis
Soy and Women's Health
Soy Foods for diabetes
Soy and Infant Formula
Soy and Sports Nutrition
Commonly Asked Questions
Bibliography/Reference
Soy & Women's Health

References for Soy & Women's Health:

  1. Setchell KDR, Cassidy A, Dietary isoflavones: biological effects and relevance to human health, J Nutr 1999;129:758S-767S.
  2. Knight DC, Lyons Wall P, Eden JA, A review of phytoestrogens and their effects in relation to menopausal symptoms, Aust J Nutr & Dietetics 1996;53:5-11.
  3. Murkies AL, Lombard C, Strauss BJG, et al., Dietary flour supplementation decreases post-menopausal hot flushes: Effect of soy and wheat, Maturitas 1995;21:189-195.
  4. Brzezinski A, Adlercreutz H, Shaoul R, et al., Short-term Effects of Phytoestrogen-rich Diet on Post-menopausal Women, Menopause 1997;4:89-94.
  5. Albertazzi P, Pansini F, Bonaccorsi G, et al., The effect of dietary soy supplementation on hot flashes, Obstet Gynecol 1998;91:6-11.
  6. Washburn S, Burke GL, Morgan T, et al., Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women, Menopause 1999;6:7-13.
  7. Dalais FS, Rice GE, Wahlqvist ML, et al., Effects of dietary phytoestrogens in postmenopausal women, Climacteric 1998;1:124-129.
  8. Heart, Stroke and Vascular Diseases Australian Facts, 1999, Australian Institute of Health and Welfare and National Heart Foundation of Australia.
  9. National Heart Foundation of New Zealand, Heart Facts, September 1997.
  10. Cassidy A, Bingham S, Setchell KDR, Biological effects of a isoflavones in young women: importance of the chemical composition of soyabean products, Br J Nutr 1995;74:587-601.
  11. Scheiber MD, Liu JH, Subbiah MTR, et al., Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women, Menopause 2000 (in press).
  12. Potter SM, Baum J, Teng H, et al., Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women, Am J Clin Nutr 1998;68(suppl):1375S-9S.
  13. Tuomilehto J, Lindstrom J, Eriksson JG et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med 2001;344:1343-1350.
  14. Brand Miller J & Foster-Powell K, The Glucose Revolution: GI Plus, Hodder, Sydney 2000.
  15. Yang G, Shu XO, Jin F et al., Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study, Eur J Clin Nutr 2004;58:615-620.
  16. Feskens EJ, Virtanen SM, Rasanen L et al., Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study, Diabetes Care 1995;18:1104-1112.
  17. Cheng SY, Shaw NS, Tsai KS et al., The hypoglycemic effects of soy isoflavones on postmenopausal women, J Womens Health (Larchmt) 2004;13:1080-1086.
  18. Jayagopal V, Albertazzi P, Kilpatrick ES et al., Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes, Diabetes Care 2002;25:1709-1714.
  19. Kannel WB & McGee DL, Diabetes and cardiovascular disease. The Framingham study JAMA 1979;241:2035-2038.
  20. Hermansen K, Sondergaard M, Hoie L et al., Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects, Diabetes Care 2001;24:228-233.
  21. Teixeira SR, Tappenden KA, Carson L et al., Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy, J Nutr 2004;134:1874-1780.
  22. Azadbakht L, Shakerhosseini R, Atabak S et al., Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy, Eur J Clin Nutr 2003;57:1292-1294.
  23. Teixeira SR, Tappenden KA, Erdman JW Jr, Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db(db/db) mice, J Nutr 2003;133:673-678.
  24. Matsuzawa Y, Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease, Atheroscler Suppl. 2005;6:7-14.
  25. Colditz GA, Willett WC, Rotnitzky A et al., Weight gain as a risk factor for clinical diabetes mellitus in women, Ann Intern Med 1995;122:481-486.
  26. Dunstan D, Zimmet P, Welborn T et al., on behalf of the AusDiab Steering Committee, Diabesity & associated disorders in Australia 2000, Melbourne, International Diabetes Institute, 2001.
  27. Ministry of Health, A Portrait of Health: Key results of the 2002/03 New Zealand Health Survey, Wellington 2004, Ministry of Health.
  28. Diabetes New Zealand website [www.diabetes.org.nz] accessed 21st June 2005.
  29. Diabetes Atlas, International Diabetes Federation website [www.idf.org] accessed 21st June 2005.

 
 Copyright © 2004 Sanitarium Health Food Company
EMAIL US FORWARD THIS PAGE TO A COLLEAGUE VISIT THE SANITARIUM SITE